BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18425411)

  • 1. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins.
    Brunger AT; Jin R; Breidenbach MA
    Cell Mol Life Sci; 2008 Aug; 65(15):2296-306. PubMed ID: 18425411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into clostridial neurotoxin-SNARE interactions.
    Breidenbach MA; Brunger AT
    Trends Mol Med; 2005 Aug; 11(8):377-81. PubMed ID: 16006188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroscience. A neuronal receptor for botulinum toxin.
    Jahn R
    Science; 2006 Apr; 312(5773):540-1. PubMed ID: 16645086
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
    Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
    J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long journey of botulinum neurotoxins into the synapse.
    Rummel A
    Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.
    Lam KH; Yao G; Jin R
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):225-231. PubMed ID: 25701633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion.
    Pellegrini LL; O'Connor V; Lottspeich F; Betz H
    EMBO J; 1995 Oct; 14(19):4705-13. PubMed ID: 7588600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
    Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
    FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology of neurosecretion and its inhibition bu tetanus and botulinum toxins (review)].
    Veit M
    Berl Munch Tierarztl Wochenschr; 1999 Jun; 112(5):186-91. PubMed ID: 10399406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of tetanus and botulinum neurotoxins binding domains.
    Lalli G; Herreros J; Osborne SL; Montecucco C; Rossetto O; Schiavo G
    J Cell Sci; 1999 Aug; 112 ( Pt 16)():2715-24. PubMed ID: 10413679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
    Gerachshenko T; Blackmer T; Yoon EJ; Bartleson C; Hamm HE; Alford S
    Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How botulinum and tetanus neurotoxins block neurotransmitter release.
    Humeau Y; Doussau F; Grant NJ; Poulain B
    Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell entry strategy of clostridial neurotoxins.
    Binz T; Rummel A
    J Neurochem; 2009 Jun; 109(6):1584-95. PubMed ID: 19457120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.
    Schiavo G; Rossetto O; Montecucco C
    Semin Cell Biol; 1994 Aug; 5(4):221-9. PubMed ID: 7994006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA; Stevens RC
    Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The core membrane fusion complex governs the probability of synaptic vesicle fusion but not transmitter release kinetics.
    Finley MF; Patel SM; Madison DV; Scheller RH
    J Neurosci; 2002 Feb; 22(4):1266-72. PubMed ID: 11850454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments.
    Pirazzini M; Azarnia Tehran D; Leka O; Zanetti G; Rossetto O; Montecucco C
    Biochim Biophys Acta; 2016 Mar; 1858(3):467-74. PubMed ID: 26307528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering.
    Binz T; Sikorra S; Mahrhold S
    Toxins (Basel); 2010 Apr; 2(4):665-82. PubMed ID: 22069605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.